The Board of directors of Tatva Chintan Pharma Chem Ltd has recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs. 22,16,50,620/- (2,21,65,062 equity shares of Rs. 10/- each) for the financial year 2022-23. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 1823.60 as compared to the previous close of Rs. 1835.95. The total number of shares traded during the day was 3463 in over 649 trades.
The stock hit an intraday high of Rs. 1845.00 and intraday low of 1784.10. The net turnover during the day was Rs. 6273425.00.